Perinatal grand rounds

Update on Congenital Syphilis

Rates of syphilis and congenital syphilis have increased significantly over the past five to seven years. What should providers know about this growing problem? What should providers do about it? This session provides an update on congenital syphilis epidemiology and addresses diagnostic and management issues.

Register to unlock the course, then click ‘Continue.’ Course materials are available at the bottom of this page.
Write your awesome label here.
Patrick Jones - Course author
Meet the instructor

Elizabeth Daniels, MD

Elizabeth Daniels is a Pediatric Infectious Disease specialist in St. Louis Missouri. She completed medical school at Washington University School of Medicine in St. Louis, MO, and pediatric residency and infectious disease fellowship training at St. Louis Children's Hospital. Her areas of interest include congenital syphilis, pediatric HIV and STI care, and infection prevention.

 

The speaker has no relevant financial relationships with ineligible companies.*

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Describe the changing epidemiology of congenital syphilis.
  • Explain the diagnosis and management of syphilis during pregnancy and congenital syphilis.
  • Assess strategies to reduce rates of congenital syphilis.


Accreditation Statement

The Wisconsin Association for Perinatal Care (WAPC) is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. The Wisconsin Association for Perinatal Care (WAPC) designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*

Course Information

This webinar was recorded on 20 November 2025.

The expiration date for this course is 20 November, 2028.

*Ineligible companies are those whose primary business in producing, marketing, selling, reselling, or distributing health care products used by or on patients.